CureVac says COVID-19 vaccine was 48% effective in key study
July 01, 2021 at 05:27 AM EDT
German company CureVac released the final results for its once-promising Covid-19 vaccine, finding it provided less protection than the vaccines already authorized for use in the U.S.
